Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

------------------------------------------------------------

March 15, 2002

"U.S. Lab to Trial Aventis Anti-AIDS Vaccine, Schering Plough Drug" AFX Asia (www.afxnews.com) (03/14/02)

The first U.S. clinical study of an Aventis AIDS vaccine will be undertaken by the Institute of Human Virology at the University of Maryland.  The product fosters the production of antibodies against the Tat protein located in HIV cells.  Schering-Plough's SCH-C AIDS drug will also be tested by the lab.  The drug targets the CCR5 immune-cell surface protein used by HIV to enter the cells and infect them.

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.